Big News: FDA is moving from MasterControl to ComplianceQuest.See Why
Talk to a SpecialistLoading…
Talk to a SpecialistTalk to a SpecialistMing Fai Industrial-Shenzhen Co LTD, a drug manufacturer, received an FDA Warning Letter on April 5, 2018, indicating significant regulatory compliance concerns. Based on the limited metadata available, the specific violations cannot be detailed as the letter's subject line is not accessible in this summary. The warning pertains to drug products under FDA jurisdiction, though the specific issuing office and violation details would require review of the complete correspondence for full regulatory context.